Monoclonal antibody and hybridoma producing the same
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Oct 14, 2008
Grant Date -
Nov 9, 2006
app pub date -
Mar 15, 2004
filing date -
Mar 14, 2003
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The present invention establishes a simple and a highly sensitive detection method for hEPR and provides a novel detection method for human tumors which express hEPR. In particular, the present invention provides a monoclonal antibody which specifically recognizes human epiregulin (hEPR), hybridoma which produces the monoclonal antibody, and a highly sensitive detection method for hEPR using the monoclonal antibody.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully